Erscheinungsdatum: 07.11.2017, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: Atlas of AIDS Co-infection, Redaktion: Jinxin, Liu // Xiaoping, Tang, Verlag: Gruyter, Walter de GmbH // De Gruyter, Sprache: Englisch, Schlagworte: Medizin // Allgemeines // Einführung // Lexikon // Kunstgeschichte // MEDICAL // Internal Medicine // allgemein // Klinische und Innere Medizin, Rubrik: Medizin // Allgemeines, Lexika, Seiten: 305, Gewicht: 546 gr, Verkäufer: averdo
Erscheinungsdatum: 27.05.2018, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: Burden of HIV-TB Co-infection, Titelzusatz: Public Health Burden Of Opportunistic Tuberculosis Infection Among Hiv/aids Patients Of Art Clinic, Bharatpur, Nepal, Autor: Kandel Poudel, Bandana, Verlag: LAP Lambert Academic Publishing, Sprache: Englisch, Rubrik: Wirtschaft // Wirtschaftsratgeber, Seiten: 100, Informationen: Paperback, Gewicht: 167 gr, Verkäufer: averdo
Erscheinungsdatum: 30.01.2016, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: Risk factors associated with TB co-infection in HIV/AIDS patients, Autor: Amente Megersa, Obsa, Verlag: LAP Lambert Academic Publishing, Sprache: Englisch, Rubrik: Medizin // Allgemeines, Lexika, Seiten: 84, Informationen: Paperback, Gewicht: 142 gr, Verkäufer: averdo
Tuberculosis (TB) is the most common opportunistic infection among HIV-infected and one of the major global public health challenges of this era.In Nepal, the burden of TB among HIV infected had been seen range from 10% - 20 % mainly the people of productive age. This study was designed to assess the public health burden of opportunistic TB infection among HIV infected. Information was collected from 144 HIV/AIDS patient who had visited the ART clinic of Bharatpur Hospital, Chitwan during the period of 10th May to 30th May 2012. Study showed the 9.7 percent prevalence of opportunistic TB among HIV infected and extra pulmonary TB rate was higher. The status of TB co-infection during the diagnosed HIV infected period was 28.4 percent including prevalence TB cases. The common health problems faced by HIV-TB co-infected were weakness , fever, weight loss and cough. Having history of TB infection before HIV diagnosis were at 4.8 times greater risk of getting opportunistic TB. Access to health related local non government organization in the community had a great impact for significantly low risk of HIV-TB co-infection.
Sierra Leone is still painfully crawling out of a decade-long civil strife that plunged the nation into decades of retrogression. The economy of the country plummeted during the war periods of 1991 to 2001, human resources dwindled, health care services where abysmal and there was a general resource poverty and its accompanying traits of malnutrition. During the war periods, a platform for disease transmission and spread was set causing many to die from curable as well as incurable diseases. The spread of tuberculosis was favoured by the war related congestion, malnutrition and poor healthcare that continued even after the war. Tuberculosis remain a cause for concern especially in situations where HIV and AIDS are also becoming a concern. The country suffers from antibiotic-resistant recurrent tuberculosis infection, multiple co-infections among others. This piece delves into the successes and failures of tuberculosis control in a resource deficient setting.
HIV and tuberculosis are commonly called the "deadly duo" because HIV weakens the body's defense system, making people more prone to developing TB. People with HIV are up to 50 times more likely to develop TB in a given year than HIV-negative people. TB bacteria also accelerate the progression of HIV to AIDS and, as a result, TB is the leading cause of death for people with HIV. Globally, an estimated 13 percent of TB cases are co-infected with HIV. Without proper treatment, 90 percent of people living with HIV die within months of contracting TB. The current challenge is to find ways of preventing both TB and HIV, and to improve diagnosis and management of co-infection.
Malaria and HIV are serious public health concerns globally but more so in sub-Saharan Africa. The relatively high prevalence of malaria and HIV/AIDS results in incidences of co-infection. There are more and more patients infected with HIV being initiated on highly active antiretroviral therapy. Artemether-lumefantrine, the recommended treatment of malaria, is therefore by necessity being prescribed alongside antiretroviral medicines in cases of malaria and HIV co-infection. There is need for more information on the influence of nevirapine and efavirenz based antiretroviral therapy on the pharmacokinetics of lumefantrine and the safety and tolerability of administering these medicines concomitantly. A parallel, open label, non-randomized study evaluating the pharmacokinetics of lumefantrine and the safety and tolerability of administering the antiretroviral and anti-malaria agents is evaluated. The findings should provide more information to the public and health workers and professionals who are dealing with this health issue.